Cell cycle regulatory failure in neurones: Causes and consequences

Neurobiology of Aging

Volumn 21, Issue 6, 2000, Pages 761-769

  Nagy, Zsuzsanna ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alzheimer's disease; Apoptosis; Cell cycle; Homocysteine

Indexed keywords

AMYLOID; BIOCHEMICAL MARKER; CYCLIN A; CYCLIN B; CYCLIN D; CYCLIN DEPENDENT KINASE 4; CYCLIN E; KI 67 ANTIGEN; PROTEIN P53; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; DNA DAMAGE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HYPOXIA; IN VITRO STUDY; NERVE CELL CULTURE; NERVE DEGENERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPSE;

AGING; ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; BRAIN; CELL CYCLE; CYCLINS; HUMANS; NEURONS; SIGNAL TRANSDUCTION;

EID: 0033634990     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00223-2     Document Type: Article

References (82)

1. DNA damage and apoptosis in Alzheimer's disease; colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay
2. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease
3. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease
4. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease
5. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease
6. Thyroid hormones and brain development
7. Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation
8. The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells
9. Transient hypoxia may lead to neuronal proliferation in the developing mammalian brain; from apoptosis to cell cycle completion
10. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain
11. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture; insights into Alzheimer's disease
12. Oxidative stress and Alzheimer disease
13. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease
14. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
15. Mitotic signaling by beta-amyloid causes neuronal death
16. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease
17. Basic transcription element-binding protein (BTEB) is a thyroid hormone-regulated gene in the developing central nervous system. Evidence for a role in neurite outgrowth
18. Growth arrest failure, G1 restriction point override, and S phase death of sensory precursor cells in the absence of neurotrophin-3
19. Generation of neurons by transient expression of neural bHLH proteins in mammalian cells
20. Apoptosis and the cell cycle
21. Growth promotion by homocysteine but not by homocysteic acid; a role for excessive growth in homocystinuria or proliferation in hyperhomocysteinemia?
22. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3
23. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death
24. Cell cycle control in mammalian cells; role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)
25. Vitamin E, and Alzheimer disease; the basis for additional clinical trials
26. Apolipoprotein E inhibits platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase
27. Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain
28. A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry
29. Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation
30. Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain
31. Homocysteine and hypomethylation. A novel link to vascular disease
32. Aging-associated neuropathology in Werner syndrome
33. p53, the cellular gatekeeper for growth and division
34. Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion
35. Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments
36. Homocysteine increases cyclin-dependent kinase in aortic rat tissue
37. Apoptosis, oncosis, and necrosis. An overview of cell death
38. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells
39. Recent advances on neuronal caspases in development and neurodegeneration
40. Oxyradicals, and DNA damage
41. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes
42. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease
43. Apolipoprotein E restricts interleukin-dependent T lymphocyte proliferation at the G1A/G1B boundary
44. Neuronal cyclin expression in the hippocampus in temporal lobe epilepsy
45. Cell cycle markers in the hippocampus in Alzheimer's disease
46. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions
47. The cell division cycle and the pathophysiology of Alzheimer's disease
48. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease
49. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis
50. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration
51. The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation
52. The regulation of cyclin-dependent kinase inhibitors (CKIs)
53. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis; relevance to Alzheimer's disease
54. Bcl-2 and p53; role in dopamine-induced apoptosis and differentiation
55. Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia
56. G1/S regulatory mechanisms from yeast to man
57. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax
58. Immunohistochemical examination of the INK4 and Cip inhibitors in the rat neonatal cerebellum; cellular localization and the impact of protein calorie malnutrition
59. Oxidative stress in neurodegenerative diseases
60. Modulation of Bcl-2 expression; a potential component of estrogen protection in NT2 neurons
61. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease
62. Apolipoprotein E. High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
63. Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein
64. Cockayne's syndrome; report of two autopsy cases associated with neurofibrillary tangles
65. Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures
66. Cyclin-dependent kinase 5 (Cdk5) and neuronne-specific activators
67. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy; a modulator of in vivo programmed cell death?
68. GADD45 is induced in Alzheimer's disease, and protects against apoptosis in vitro
69. Localization and expression of cdc2 and cdk4 in Alzheimer brain tissue
70. Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain; comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto-oncogene Bax
71. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain
72. Mitotic mechanisms in Alzheimer's disease?
73. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease
74. Apolipoprotein E; a potent inhibitor of endothelial and tumor cell proliferation
75. Overlapping and divergent actions of estrogen and the neurotrophins on cell fate and p53-dependent signal transduction in conditionally immortalized cerebral cortical neuroblasts
76. Regionally specific loss of neurons in the aging human hippocampus
77. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
78. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death
79. Heterodimerization with Bax is required for Bcl-2 to repress cell death
80. Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases